AN1 — Anagenics Balance Sheet
0.000.00%
Last trade - 00:00- AU$3.79m
- AU$3.31m
- AU$9.11m
- 12
- 80
- 28
- 37
Annual balance sheet for Anagenics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | C2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 3.08 | 6.97 | 6.73 | 3.28 | 2.57 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.29 | 1.87 | 1.8 | 0.921 | 1.09 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 7.23 | 11.6 | 11.3 | 8.77 | 6.25 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.8 | 1.5 | 0.58 | 0.691 | 0.836 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 9.79 | 14.9 | 13.3 | 12.9 | 11.1 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.91 | 3.64 | 1.92 | 3.66 | 1.71 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3.93 | 5.08 | 2.86 | 4.64 | 2.22 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 5.86 | 9.81 | 10.4 | 8.29 | 8.9 |
| Total Liabilities & Shareholders' Equity | 9.79 | 14.9 | 13.3 | 12.9 | 11.1 |
| Total Common Shares Outstanding |